Clinical Trials Browser

Phase NA × Blood Specimen Collection × Genitourinary × Clear all

NCT07555600 2026-04-29

E-FACTOR

Phase NA Not yet recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT06020651 2026-04-08

VICKI

Phase NA Completed

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT02822404 2026-04-01

CysPed

Phase NA Completed

Kidney Diseases

NCT06435546 2026-03-27

AdOTAC

Phase NA Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT03185039 2026-03-19

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Phase NA Active not recruiting

Kidney Neoplasms

NCT07463508 2026-03-11

TG-BIL

Phase NA Recruiting

Testicular Neoplasms

NCT04662996 2026-02-12

MiR_CPMRC

Phase NA Completed

Prostatic Neoplasms, Disease Resistance

NCT07406646 2026-02-12

EXO-RENAL1

Phase NA Completed

Carcinoma, Renal Cell

NCT05890781 2026-02-09

IMMUNEORGANOID

Phase NA Recruiting

CNSGenitourinarySarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Neuroblastoma, Sarcoma

NCT06600802 2025-12-31

PSMA-PRED

Phase NA Recruiting

Castration-resistant Metastatic Prostate Cancer

NCT05141383 2025-09-08

HOPE

Phase NA Completed

Disease, Prostatic Neoplasms

NCT05151341 2025-07-24

URODX-FGFR3

Phase NA Completed

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT06896162 2025-07-11

PROGRESS

Phase NA Recruiting

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT04581109 2025-07-10

EPIDROP

Phase NA Recruiting

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT04823923 2025-02-12

IREKI

Phase NA Recruiting

Kidney Neoplasms, Renal Insufficiency

NCT04732156 2024-02-28

CHANGE

Phase NA Recruiting

Prostatic Neoplasms

NCT04324983 2023-04-12

BioPoP

Phase NA Completed

Prostate Cancer Recurrent

NCT03987568 2022-12-21

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

Phase NA Withdrawn

Prostatic Neoplasms

NCT05426317 2022-06-22

Onco-PDL1s/B2M

Phase NA Unknown

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT02235142 2022-01-20

AndroCan

Phase NA Completed

Prostatic Neoplasms

NCT04556916 2022-01-04

PROLIPSY

Phase NA Recruiting

Prostatic Neoplasms

NCT02485964 2021-10-07

A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine

Phase NA Completed

10 enrolled 6 charts

Prostatic Neoplasms

NCT03787056 2021-07-16

ONCOPRO

Phase NA Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT04774133 2021-03-01

The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.

Phase NA Unknown

Prostatic Neoplasms

NCT03331367 2020-08-07

Investigating and Characterizing the Immune Response to Prostate Cancer

Phase NA Completed

Prostatic Neoplasms

NCT02963155 2020-01-10

NKPROSTATE

Phase NA Unknown

Neoplasm Metastasis, Prostatic Neoplasms

NCT00798876 2019-05-07

Low-Fat Fish Oil Diet for Prostate Cancer Prevention

Phase NA Completed

Prostatic Neoplasms

NCT01598038 2017-07-28

Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma

Phase NA Terminated

Carcinoma, Renal Cell, Neoplasms